GROWTH STOCK ANALYZER Open the app
Growth Stock Analyzer › ARVN growth analysis
Growth stock analysis · updated 2026-07-28

Arvinas, Inc (ARVN) growth stock analysis

Is Arvinas, Inc a growth stock? A data-driven read on its earnings momentum, price leadership, and demand, scored against every US stock from SEC filings and daily prices, and re-ranked after every close.

Not right now by CANSLIM
12
Growth score
24
RS rating
#4,340
Rank
0/6
Traits passed
12/99
Growth score · 4340th of 4,892 US stocks
CANSLI
Six growth traits, scored 1–99

What the data says about ARVN

As of the 2026-07-28 close, ARVN scores 12 out of 99 on our growth-stock rating, a weak growth-stock profile. That ranks it 4340th of 4,892 rated US stocks, the top 89% of the market.

Its strongest trait is I (institutional sponsorship) at 40, and its weakest is A (annual earnings growth) at 0. ARVN clears 0 of the six core growth traits we score per stock; the seventh, overall market direction, is judged market-wide.

On price, ARVN carries a lagging Relative Strength rating of 24, meaning it has outperformed about 24% of the market over the past year.

Underneath the score: quarterly earnings down 179% year over year, sales down 92%, trading 41% below its 52-week high.

ARVN growth-trait breakdown

The six traits that separate real growth stocks from the rest: earnings, price leadership, and demand. Each is scored 1–99 against the whole US market. We compute them with the CANSLIM method, double-weighting earnings and relative strength.

C
Current quarterly earnings
most recent EPS growth vs. a year ago
7
A
Annual earnings growth
multi-year earnings trend
0
N
New highs & catalysts
proximity to new 52-week highs
10
S
Supply & demand
volume behind the move vs. share supply
39
L
Leader or laggard
Relative Strength within its group
30
I
Institutional sponsorship
fund accumulation and 13F ownership
40

Is ARVN a growth stock?

Not right now by CANSLIM

On today’s data ARVN does not clear the growth-stock bar CANSLIM sets. Scores are re-computed after every close, so this can change.

🔒 Stronger growth stocks than ARVN

The stocks ranking above ARVN today, the growth leaders you’d weigh against it.

See today’s top ranks for free →

🔒 ARVN price history & buy range

Where ARVN sits in its base, its 52-week path, and the trait trend over the past year.

Open the full ARVN profile →

See where ARVN ranks among every US growth stock

Every US stock scored on the traits that define a growth stock and re-ranked after each close, with the top ranks, the full trait breakdown, and today’s market read.

Open the app, free through September 1

ARVN as a growth stock, frequently asked

Is ARVN a good growth stock?

Not right now by CANSLIM. On today’s data ARVN does not clear the growth-stock bar CANSLIM sets. Scores are re-computed after every close, so this can change.

What is ARVN's growth score?

Arvinas, Inc (ARVN) scores 12 out of 99 on our growth-stock rating as of the 2026-07-28 close, ranking 4340th of 4,892 rated US stocks.

Does ARVN have strong earnings growth?

ARVN's most recent quarterly earnings were down about 179% year over year, with sales down 92%.

How strong is ARVN's price performance?

ARVN has a Relative Strength rating of 24, meaning it has outperformed roughly 24% of the US market over the trailing year.

Where can I see ARVN's full analysis?

Create a free Growth Stock Analyzer account to see where ARVN ranks against every US stock, the stronger growth stocks to weigh against it, and its full price and earnings history.

Want the method behind the score? Read how we grade growth stocks with CANSLIM.

More growth stocks in Pharmaceutical Preparations